0001209191-11-034643.txt : 20110614
0001209191-11-034643.hdr.sgml : 20110614
20110614191108
ACCESSION NUMBER: 0001209191-11-034643
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20110614
FILED AS OF DATE: 20110614
DATE AS OF CHANGE: 20110614
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDERA PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000861838
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043072298
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 167 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6176795500
MAIL ADDRESS:
STREET 1: 167 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: HYBRIDON INC
DATE OF NAME CHANGE: 19951211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WYNGAARDEN JAMES B
CENTRAL INDEX KEY: 0001022940
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31918
FILM NUMBER: 11911653
MAIL ADDRESS:
STREET 1: C/O GENAERA CORP
STREET 2: 5110 CAMPUS DRIVE
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
4
1
doc4.xml
FORM 4 SUBMISSION
X0303
4
2011-06-14
0
0000861838
IDERA PHARMACEUTICALS, INC.
IDRA
0001022940
WYNGAARDEN JAMES B
3504 STONEYBROOK DRIVE
DURHAM
NC
27705
1
0
0
0
Stock Option
2.18
2011-06-14
4
A
0
20000
0.00
A
2021-06-14
Common Stock
20000
20000
D
The option vests in twelve equal quarterly installments over three years, beginning on September 14, 2011.
/s/ Louis J. Arcudi III, Attorney-in-Fact
2011-06-14
EX-24.4_382611
2
poa.txt
POA DOCUMENT
LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATION
I, James B. Wyngaarden, hereby make, constitute and appoint Louis J. Arcudi III
signing singly and acting individually, as my true and lawful attorney in fact
with full power and authority as hereinafter described to:
(1) execute for and on my behalf, in my capacity as a director of Idera
Pharmaceuticals, Inc. (the "Company"), the attached Form 4 (including any
amendments thereto) in accordance with Section 16(a) of the Securities Exchange
Act of 1934 and the rules thereunder (the "Exchange Act");
(2) do and perform any and all acts for and on my behalf which may be necessary
or desirable to prepare, complete and execute any such Form 4, prepare, complete
and execute any amendment or amendments thereto, and timely deliver and file
such form with the United States Securities and Exchange Commission (the "SEC")
and any stock exchange or similar authority; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney in fact, may be of benefit to,
in the best interest of, or legally required by, me, it being understood that
the documents executed by such attorney in fact on my behalf pursuant to this
Power of Attorney shall be in such form and shall contain such terms and
conditions as such attorney in fact may approve in such attorney in fact's
discretion.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 14th day of June, 2011.
/s/ James B. Wyngaarden
James B. Wyngaarden